These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10513982)

  • 1. Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum.
    Papadopoulos V; Dharmarajan AM; Li H; Culty M; Lemay M; Sridaran R
    Biochem Pharmacol; 1999 Nov; 58(9):1389-93. PubMed ID: 10513982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy.
    Sridaran R; Philip GH; Li H; Culty M; Liu Z; Stocco DM; Papadopoulos V
    J Mol Endocrinol; 1999 Feb; 22(1):45-54. PubMed ID: 9924179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist.
    Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R
    Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation.
    Sridaran R; Mahesh VB
    Biol Reprod; 1989 Feb; 40(2):276-82. PubMed ID: 2655722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin.
    Del Canto F; Sierralta W; Kohen P; Muñoz A; Strauss JF; Devoto L
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4436-43. PubMed ID: 17698899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
    Sridaran R; Ghose M; Mahesh VB
    Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat.
    Yang H; Bhat GK; Wadley R; Wright KL; Chung BM; Whittaker JA; Dharmarajan AM; Sridaran R
    Biol Reprod; 2003 Jun; 68(6):2222-31. PubMed ID: 12606359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production.
    Clayton RN; Harwood JP; Catt KJ
    Nature; 1979 Nov; 282(5734):90-2. PubMed ID: 228197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identical changes in Bax expression, but not Fas ligand expression, occur in structural luteolysis in gonadotropin releasing hormone agonist- and prolactin-treated superovulated rats.
    Endo T; Kiya T; Kitajima Y; Honnma H; Chida M; Hayashi T; Henmi H; Yamazaki K; Hayashi T; Manase K; Kudo R
    Life Sci; 2005 Mar; 76(19):2159-69. PubMed ID: 15733931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants mimic the ability of chorionic gonadotropin to suppress apoptosis in the rabbit corpus luteum in vitro: a novel role for superoxide dismutase in regulating bax expression.
    Dharmarajan AM; Hisheh S; Singh B; Parkinson S; Tilly KI; Tilly JL
    Endocrinology; 1999 Jun; 140(6):2555-61. PubMed ID: 10342842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells.
    Boujrad N; Vidic B; Gazouli M; Culty M; Papadopoulos V
    Endocrinology; 2000 Sep; 141(9):3137-48. PubMed ID: 10965884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by droloxifene and C-myc, Bax, Bcl-2 protein expression in corpus luteum of pregnant rats.
    Leng Y; Gu ZP; Cao L
    Acta Pharmacol Sin; 2001 Apr; 22(4):327-34. PubMed ID: 11742585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
    Sutter AP; Maaser K; Grabowski P; Bradacs G; Vormbrock K; Höpfner M; Krahn A; Heine B; Stein H; Somasundaram R; Schuppan D; Zeitz M; Scherübl H
    J Hepatol; 2004 Nov; 41(5):799-807. PubMed ID: 15519653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.
    Shimizu S; Narita M; Tsujimoto Y
    Nature; 1999 Jun; 399(6735):483-7. PubMed ID: 10365962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-X(L) and calyculin A prevent translocation of Bax to mitochondria during apoptosis.
    Ganju N; Eastman A
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1258-64. PubMed ID: 11883953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of GnRH analogs on the expression of Bcl-2 gene family in the ovary of rats with cyclophosphamide-induced ovarian damage].
    Peng P; Yang DZ; Yang CH; Zhang W; Zhang YL; Liu J; Ye CL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2014-7. PubMed ID: 19033116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies on the role of the peripheral benzodiazepine receptor (PBR) in steroidogenesis.
    Papadopoulos V; Widmaier EP; Amri H; Zilz A; Li H; Culty M; Castello R; Philip GH; Sridaran R; Drieu K
    Endocr Res; 1998; 24(3-4):479-87. PubMed ID: 9888528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: regulation by epidermal growth factor and the expression of Bcl-2-related genes.
    Parborell F; Pecci A; Gonzalez O; Vitale A; Tesone M
    Biol Reprod; 2002 Aug; 67(2):481-6. PubMed ID: 12135885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse uterine epithelial apoptosis is associated with expression of mitochondrial voltage-dependent anion channels, release of cytochrome C from mitochondria, and the ratio of Bax to Bcl-2 or Bcl-X.
    Takagi-Morishita Y; Yamada N; Sugihara A; Iwasaki T; Tsujimura T; Terada N
    Biol Reprod; 2003 Apr; 68(4):1178-84. PubMed ID: 12606449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.